Elan announces agreement to co-promote new migraine drug FROVA
Elan Corporation, plc and UCB Pharma, Inc., the US affiliate of a Belgium R&D-based international pharmaceutical and chemical
group, announced today that they have entered into an agreement to co-promote the new migraine drug FROVA in the United Stat
8:17AM ( 23 years ago )